PEGY
← Back to signals

DGX

BUY

Quest Diagnostics Incorporated

Health Care

0.81
PEGY ratio
Rank #117
Why This Matters

This stock appears undervalued relative to its growth and dividend yield. Strong projected growth of 29.1% annually over 5 years. Pays a 1.8% dividend yield.

DGX trades at 21.6x earnings against 25.0% capped growth (actual 29.1%) + 1.8% yield (PEGY 0.81). Valuation looks favorable — the price is not fully reflecting the growth and yield on offer.

~ Growth estimate uses historical CAGR (forward estimates unavailable)

  • Growth rate derived from historical CAGR — limited analyst coverage.
  • Growth rate capped at 25% for PEGY calculation (actual: 29.1%). Per Peter Lynch methodology, growth above 25% is rarely sustainable over 5 years.

Scan date: 2026-05-29

Valuation
21.6x
P/E Ratio
Growth
29.1%
5yr EPS
Income
1.8%
Div Yield
PEGY Components
PEGY Score0.81
Denominator26.8%
EPS (TTM)$9.04
Market Data
Price$194.90
ExchangeNYSE
S&P 500
What Changed
PEGY Score
0.810.81(+0.00)
Rank
#117#117(0 positions)

vs 7 days ago

Portfolio Context

Founder does not hold this stock.

Not in your portfolio.

Sector: Health Care

PEGY History — 90 days
Data: Yahoo Finance • Updated nightly 11 PM ET • For informational purposes only